SINGAPORE (Bloomberg): Thousands of parents in Singapore are furious, with some now pursuing legal action, after a major operator of cord blood banks in Asia irreparably damaged their children’s samples through improper handling.
The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. The scandal now engulfing Cordlife Group Ltd. has implications across the region, given its operations in Hong Kong, Macau, Indonesia, the Philippines and India.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
